Our group has shown that the transcription factor NF-kB (p100/p52) is overexpressed in NSCLC, with NF-kB2 immunopositivity being associated with regional lymph node infiltration, tumor stage and tumor grade15. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.